Julita Chlebowicz

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Molecular Docking

Top Venues

Drug design, development and therapy

Science advances

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Julita Chlebowicz, William P Russ, Dailu Chen, Anthony R Vega, Steven Vernino, Charles L White, Josep Rizo, Lukasz A Joachimiak, Marc I Diamond
Saturation mutagenesis of α-synuclein reveals monomer fold that modulates aggregation. Science advances 9 (43) (2023)
Julita Chlebowicz, Radha Akella, John M Humphreys, Haixia He, Ashari R Kannangara, Shuguang Wei, Bruce A Posner, Elizabeth J Goldsmith
Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening. Drug design, development and therapy 17 (2023)
Julita Chlebowicz, Radha Akella, John M Humphreys, Haixia He, Ashari R Kannangara, Shuguang Wei, Bruce A Posner, Elizabeth J Goldsmith
Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening. Drug design, development and therapy 17 (2023)
Julita Chlebowicz, Radha Akella, John M Humphreys, Haixia He, Ashari R Kannangara, Shuguang Wei, Bruce A Posner, Elizabeth J Goldsmith
Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening. Drug design, development and therapy 17 (2023)
Melanie Rodriguez, Ashari Kannangara, Julita Chlebowicz, Radha Akella, Haixia He, Uttam K Tambar, Elizabeth J Goldsmith
Synthesis and Structural Characterization of Novel Trihalo-sulfone Inhibitors of WNK1. ACS medicinal chemistry letters 13 (10) (2022)